Implementation of oral care in primary diabetes care in the Netherlands

Best practice model for interdisciplinary medicine in treating diabetes patients. The need for implementation of oral care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10145611

Enrollment

2400

Registered

2017-02-01

Start date

2015-03-01

Completion date

Unknown

Last updated

2023-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2 Nutritional, Metabolic, Endocrine Diabetes Mellitus Type 2

Interventions

24 participating GP practices are randomly 24 participating GP practices are randomly allocated to either the control group or the intervention group, using the SNOSE (sequentially numbered, opaque, s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and over 2. Diabetes mellitus Type 2 3. Follows the standardized primary diabetes care protocol 4. Understands spoken and written Dutch

Exclusion criteria

Exclusion criteria: 1. Don't understand spoken and written Dutch 2. Attend secondary diabetes care (i.e. internal medicine at the hospital)

Design outcomes

Primary

Measure	Time frame
1. Self-reported oral health, using a questionnaire based on large epidemiological studies from the United States, measured at baseline and 12 months 2. Oral health is assessed using an oral examination by a dentist at baseline and 12 months 3. Oral health related quality of life is assessed using the OHIP-14 questionnaire at baseline and 12 months 4. General quality of life is assessed using the SF-36 questionnaire at baseline and 12 months	—

Measure

Time frame

1. Self-reported oral health, using a questionnaire based on large epidemiological studies from the United States, measured at baseline and 12 months 2. Oral health is assessed using an oral examination by a dentist at baseline and 12 months 3. Oral health related quality of life is assessed using the OHIP-14 questionnaire at baseline and 12 months 4. General quality of life is assessed using the SF-36 questionnaire at baseline and 12 months

—

Secondary

Measure	Time frame
Parameters of protocolization and optimalization: 1. Number of patients which are referred to a specialist by the dentist during the 12 months follow up. This is registered by the dentist on the return form that the patient received at baseline. 2. Number of patients which are seen by the dentist is measured by the number of return forms that the GP practices received during the 12 months follow-up 3. Number of patients which are treated by the dentist is registered on the return forms that the they received during the 12 months follow-up 4. Feasibility and effectiveness of our intervention protocol is assessed using a questionnaire related to the opinion of diabetes practitioners, measured as soon as they finished the follow-up period. Change in general health as recorded by the diabetes practitioner: 1. Number and severity of diabetes-related complications is assessed through medical record review at baseline and 12 months 2. (Bio)markers of metabolic control of diabetes mellitus (Glucose, HbA1c, Lipids, etc..) is assessed through medical record review at baseline and 12 months 3. General characteristics (BMI, smoking habits, diet, etc..) is assessed through medical record review at baseline and 12 months 4. Medication use is assessed through medical record review at baseline and 12 months	—

Measure

Time frame

Parameters of protocolization and optimalization: 1. Number of patients which are referred to a specialist by the dentist during the 12 months follow up. This is registered by the dentist on the return form that the patient received at baseline. 2. Number of patients which are seen by the dentist is measured by the number of return forms that the GP practices received during the 12 months follow-up 3. Number of patients which are treated by the dentist is registered on the return forms that the they received during the 12 months follow-up 4. Feasibility and effectiveness of our intervention protocol is assessed using a questionnaire related to the opinion of diabetes practitioners, measured as soon as they finished the follow-up period. Change in general health as recorded by the diabetes practitioner: 1. Number and severity of diabetes-related complications is assessed through medical record review at baseline and 12 months 2. (Bio)markers of metabolic control of diabetes mellitus (Glucose, HbA1c, Lipids, etc..) is assessed through medical record review at baseline and 12 months 3. General characteristics (BMI, smoking habits, diet, etc..) is assessed through medical record review at baseline and 12 months 4. Medication use is assessed through medical record review at baseline and 12 months

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026